Effectiveness of Artificial Intelligence for Personalized Medicine in Neoplasms: A Systematic Review.

Purpose. Artificial intelligence (AI) techniques are used in precision medicine to explore novel genotypes and phenotypes data. The main aims of precision medicine include early diagnosis, screening, and personalized treatment regime for a patient based on genetic-oriented features and characteristi...

Descripción completa

Detalles Bibliográficos
Publicado en:BioMed Research International pp. 1 - 35
Autores principales: Rezayi, Sorayya, R Niakan Kalhori, Sharareh, Saeedi, Soheila
Formato: research systematic review tables/charts Journal Article
Publicado: Wiley-Blackwell 4/7/2022
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=156201700&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 156201700
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        23146133
        FT2T
      jtl: BioMed Research International
      issn: 23146133
      maglogo: N
    pubinfo:
      dt: 4/7/2022
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        156201700
        156201700
        156201700
        10.1155/2022/7842566
        156201700
      ppf: 1
      ppct: 34
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Effectiveness of Artificial Intelligence for Personalized Medicine in Neoplasms: A Systematic Review.
      aug:
        au:
          Rezayi, Sorayya
          R Niakan Kalhori, Sharareh
          Saeedi, Soheila
        affil: Ph.D. Candidate in Medical Informatics, Health Information Management and Medical Informatics Department, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran
      sug:
        subj:
          Artificial Intelligence
          Individualized Medicine
          Neoplasms Diagnosis
          Neoplasms Prevention and Control
          Neoplasms Therapy
          Early Detection of Cancer Methods
          Cancer Screening Methods
          Human
          Systematic Review
          PubMed
          Medline
          Embase
          Cochrane Library
          Sensitivity and Specificity
          Random Forest
          Decision Trees
          Deep Learning
          Data Analysis Software
          Breast Neoplasms
          Lung Neoplasms
          Genomics
          Gene Expression
          Mutation
          Phenotype
          Proteomics
      ab: Purpose. Artificial intelligence (AI) techniques are used in precision medicine to explore novel genotypes and phenotypes data. The main aims of precision medicine include early diagnosis, screening, and personalized treatment regime for a patient based on genetic-oriented features and characteristics. The main objective of this study was to review AI techniques and their effectiveness in neoplasm precision medicine. Materials and Methods. A comprehensive search was performed in Medline (through PubMed), Scopus, ISI Web of Science, IEEE Xplore, Embase, and Cochrane databases from inception to December 29, 2021, in order to identify the studies that used AI methods for cancer precision medicine and evaluate outcomes of the models. Results. Sixty-three studies were included in this systematic review. The main AI approaches in 17 papers (26.9%) were linear and nonlinear categories (random forest or decision trees), and in 21 citations, rule-based systems and deep learning models were used. Notably, 62% of the articles were done in the United States and China. R package was the most frequent software, and breast and lung cancer were the most selected neoplasms in the papers. Out of 63 papers, in 34 articles, genomic data like gene expression, somatic mutation data, phenotype data, and proteomics with drug-response which is functional data was used as input in AI methods; in 16 papers' (25.3%) drug response, functional data was utilized in personalization of treatment. The maximum values of the assessment indicators such as accuracy, sensitivity, specificity, precision, recall, and area under the curve (AUC) in included studies were 0.99, 1.00, 0.96, 0.98, 0.99, and 0.9929, respectively. Conclusion. The findings showed that in many cases, the use of artificial intelligence methods had effective application in personalized medicine.
      pubtype: Academic Journal
      doctype:
        research
        systematic review
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N